Advertisement
Advertisement

CRDL

CRDL logo

Cardiol Therapeutics Inc. Class A Common Shares

1.00
USD
Sponsored
-0.01
-0.50%
Jan 08, 15:30 UTC -5
Closed
exchange

After-Market

1.02

+0.02
+1.49%

CRDL Earnings Reports

Positive Surprise Ratio

CRDL beat 15 of 21 last estimates.

71%

Next Report

Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.08
Implied change from Q3 25 (Revenue/ EPS)
--
/
-33.33%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-11.11%

Cardiol Therapeutics Inc. Class A Common Shares earnings per share and revenue

On Nov 13, 2025, CRDL reported earnings of -0.12 USD per share (EPS) for Q3 25, missing the estimate of -0.09 USD, resulting in a -30.72% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.08 USD, with revenue projected to reach -- USD, implying an decrease of -33.33% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
Dec 26, 2025 For Q4 25
Estimate
-$0.49
Actual
-
Surprise
-
FAQ
For Q3 2025, Cardiol Therapeutics Inc. Class A Common Shares reported EPS of -$0.12, missing estimates by -30.72%, and revenue of $0.00, 0% as expectations.
The stock price moved -- 0%, changed from $1.02 before the earnings release to $1.02 the day after.
The next earning report is scheduled for Mar 30, 2026.
Based on 3 analysts, Cardiol Therapeutics Inc. Class A Common Shares is expected to report EPS of -$0.08 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement